BRAF and neoplasm: BRAF inhibitors can reverse some of the immunosuppressive effects associated with the BRAF-mutant tumour microenvironment (discussed in Section 3), augmenting the immune response and turning them back into immunologically “hot” tumours [16,17,21,33].